Google Übersetzer
Pds Biotechnology Corporation
About
Pds Biotechnology Corporation — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 15 2026
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
Mar 30 2026
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
Mar 24 2026
PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
Feb 20 2026
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
Jan 28 2026
PDS Biotech Announces Presentation of Preliminary Results from Phase 2 Study of IL-12 Tumor Targeted Immunocytokine (PDS01ADC) in 3rd Line Metastatic Castration Resistant Prostate Cancer by the NCI
Recent Videos
PDSB STOCK : READY FOR RECOVERY | PDS BIOTECHNOLOGY STOCK
May 08, 2026
PDSB Financing Shift: My Take on the 8-K
May 01, 2026
FRESH RECOVERY | PDSB STOCK ANALYSIS | PDS BIOTECHNOLOGY STOCK
Apr 20, 2026
15 abril 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Apr 15, 2026